Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
103 participants
INTERVENTIONAL
2019-10-11
2024-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Supported Employment Demonstration
NCT03682263
Trial of Supported Employment Versus USES Supported Employment
NCT00261235
Supported Employment: Motivational Enhancement for Entry and Outcome
NCT01041976
Mastering the World of Work (MWW): RCT
NCT05206188
Efficacy of an Occupational Time Use Intervention for People With Serious Mental Illness
NCT00520728
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental Group: HYPE Services
The experimental arm will receive the HYPE intervention for 12 months.
Weekly Meetings with a Supported Employment/Supported Education Specialist
Participants will receive intervention for 12 months which includes weekly meetings with a Supported Employment/Supported Education Specialist (HYPE Specialist). During the weekly meetings, the HYPE Specialist will review each participant's education and employment goals, and deliver individualized support relevant to those goals which include use of structured HYPE tools and worksheets as needed.
Focused Skill and Strategy Training (FSST)
Participants receive a 12 week Focused Skill and Strategy Training (FSST), a structured cognitive remediation intervention.
Control Group: Enhanced Academic Services as Usual
The control arm will receive a special personalized packet of resources available on campus and off-campus within a 10-mile radius, as "enhanced academic services as usual."
Enhanced Services as Usual
One hour meetings every semester to review individual academic needs and review list of available on campus resources to best meet the student's needs.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Weekly Meetings with a Supported Employment/Supported Education Specialist
Participants will receive intervention for 12 months which includes weekly meetings with a Supported Employment/Supported Education Specialist (HYPE Specialist). During the weekly meetings, the HYPE Specialist will review each participant's education and employment goals, and deliver individualized support relevant to those goals which include use of structured HYPE tools and worksheets as needed.
Focused Skill and Strategy Training (FSST)
Participants receive a 12 week Focused Skill and Strategy Training (FSST), a structured cognitive remediation intervention.
Enhanced Services as Usual
One hour meetings every semester to review individual academic needs and review list of available on campus resources to best meet the student's needs.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* able to speak and read English fluently
* cognitively capable of providing informed consent and participating in study activities;
* enrolled in a minimum of six credits at a campus-based accredited college (two year or four-year programs)
* intending to enroll in a minimum of four semesters of college courses with the expectation of being continuously enrolled
* have had at least one prior academic disruption during a college academic semester - (e.g., withdrawal from postsecondary institutions; academic probation; not meeting satisfactory academic progress; or a prior leave of absence) prior to study enrollment
* currently have a diagnosed mental health condition by a licensed mental health provider under the DSM-V Axis 1 diagnoses (schizophrenia or other psychotic disorders, anxiety disorders, mood disorders, eating disorders, attention deficits and disruptive behavior disorders) or have been deemed eligible for ADA protections due to a disabling mental health condition - (e.g., receiving state vocational agency services, SSI/DI benefits, or postsecondary accommodations).
Exclusion Criteria
* have had no impact to academic success in college (i.e. disruption);
* have a secondary autism spectrum disorder, traumatic brain injury, or other neurodevelopmental or neurocognitive disorder affecting cognition;
* are currently incarcerated prisoners;
* are unable to speak or read English fluently;
* are under age 18 or require a legal guardian to provide informed consent;
* lack the cognitive capability to provide informed consent on their own
18 Years
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Colorado State University
OTHER
National Institute on Disability, Independent Living, and Rehabilitation Research
FED
Binghamton University
OTHER
University of Massachusetts, Worcester
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michelle Mullen
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michelle Mullen, MS
Role: PRINCIPAL_INVESTIGATOR
UMass Medical School
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Colorado State University
Fort Collins, Colorado, United States
UMass Medical School
Worcester, Massachusetts, United States
Binghamton University
Binghamton, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HHS-2019-ACL-NIDILRR-RTEM-0334
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
H00017845
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.